Clinical Trial Update: Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome [Phase 3]

View source ↗

Summary

Long-term safety data from a Phase 3 trial evaluating ropinirole XR in patients with Restless Legs Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Ropinirole XR (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED